logo
Select company
Select metric
$ 2.64MConsolidated Income
VS
Market
47
Sector
81
Industry
91
History
100
$ 10.8Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information

Ticker

ZVRA

Company Name

ZEVRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZEVRA THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZVRA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ 2.64M
3/31/2025$ -91.99M
12/31/2024$ -105.51M
9/30/2024$ -84.92M
6/30/2024$ -65.75M
3/31/2024$ -50.9M
12/31/2023$ -46.05M
9/30/2023$ -39.92M
6/30/2023$ -32.49M
3/31/2023$ -51.45M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -13.94M.
  • Over the past 5 years, ZEVRA THERAPEUTICS INC's average Cons. Inc. has been $ -37.44M.
  • The median Cons. Inc. for ZEVRA THERAPEUTICS INC during this period was $ -33.86M
  • ZEVRA THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ 2.64M.
  • The lowest Cons. Inc. recorded by ZEVRA THERAPEUTICS INC in the same timeframe $ -105.51M

ZEVRA THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
EYPT : EYEPOINT PHARMACEUTICALS INC $ -175.38MTBPH : THERAVANCE BIOPHARMA INC $ 13.03MSAGE : SAGE THERAPEUTICS INC $ -301.19MMGTX : MEIRAGTX HOLDINGS PLC $ -157.5MLXRX : LEXICON PHARMACEUTICALS INC $ -120.62MNKTR : NEKTAR THERAPEUTICS $ -122.27MKURA : KURA ONCOLOGY INC $ -197.17MGOSS : GOSSAMER BIO INC $ -138.74MNRIX : NURIX THERAPEUTICS INC $ -244.78MSNDX : SYNDAX PHARMACEUTICALS INC $ -334.99M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ZVRA - Consolidated Income, Last 5 years

$ -105.51M

Minimum

Dec 31, 2024

$ 2.64M

Maximum

Jun 30, 2025

$ -37.44M

Average

$ -33.86M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M